Suvorexant is prescribed for:
- Insomnia characterized by difficulty falling asleep
- Insomnia with difficulty maintaining sleep
- Neurologic sleep disorders
The first orexin receptor antagonist approved for insomnia.
Generic Name: Suvorexant
Brand Names: Belsomra
Suvorexant is the first approved orexin receptor antagonist for insomnia treatment.
Suvorexant is prescribed for:
The first orexin receptor antagonist approved for insomnia.
Common side effects:
Schedule IV controlled substance due to potential for abuse.
Suvorexant was the first dual orexin receptor antagonist approved for insomnia.
Blocks orexin A and B binding to OX1R and OX2R receptors, reducing wake drive rather than sedating like traditional sleep medications.
Take 10-20 mg within 30 minutes of bedtime. Do not take unless able to get 7+ hours of sleep.
Learn more at MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Suvorexant? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.